 |
plasminogen (Human) |
|---|---|
| Trade Name | Ryplazim� Plasminogen (Human) |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-14 00:00:00 |
| Sponsor | ProMetic BioTherapeutics, Inc;1330 Piccard Drive, Suite 201;Rockville, Maryland, 20850 |
